Literature DB >> 10389000

Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia.

W H Sheu, B L Juang, Y T Chen, W J Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10389000     DOI： 10.2337/diacare.22.7.1224

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

Review 1.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.

Authors:  Sandra J Hamilton; Gerald F Watts
Journal:  Rev Diabet Stud       Date:  2013-08-10

Review 3.  Statins in type 2 diabetes mellitus: target on lipids and vascular wall function.

Authors:  M A van de Ree; F V van Venrooij; A E Meinders; I J A M Jonkers; I Berk-Planken; M V Huisman
Journal:  Neth Heart J       Date:  2003-03       Impact factor: 2.380

Review 4.  Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.

Authors:  Michio Otsuki; Kayoko Goya; Soji Kasayama
Journal:  Vasc Health Risk Manag       Date:  2005

5.  Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia.

Authors:  Catalin Mindrescu; Rakesh P Gupta; Eileen V Hermance; Mary C DeVoe; Vikas R Soma; John T Coppola; Cezar S Staniloae
Journal:  Vasc Health Risk Manag       Date:  2008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.